Industrial hemp and medicinal cannabis are often thrown around as if they mean the same thing, but under Pakistan’s CCRA framework, they do not. The difference affects THC limits, licensing, product classification, and how these categories are treated in the market. CBD Pakistan helps readers make sense of that distinction with clear, grounded guidance instead of vague claims or recycled noise.
What is the difference between industrial hemp and medicinal cannabis under CCRA?
Under Pakistan’s current CCRA framework, the core difference comes down to THC threshold, regulatory treatment, and intended use. The National Cannabis Control and Regulatory Policy – 2025 describes industrial cannabis / hemp as cannabis with less than 0.3% THC, while the same policy separately refers to medicinal cannabis with THC above 0.3% and places it under stricter medical distribution rules. CCRA’s licence page reinforces that distinction by listing separate cultivation categories for Industrial Hemp Cultivation and Medicinal Cannabis Cultivation.
That means this is not just semantics. Pakistan’s regulator is drawing a line between low-THC industrial activity and higher-THC medicinal activity, and that line affects cultivation, supply chain rules, and market access.
Why CCRA separates hemp and medicinal cannabis
CCRA and Pakistan’s national policy do not separate these categories for fun. They do it to control misuse, structure the market, and regulate cannabis differently depending on THC content and purpose. The official policy frames the sector around medicinal and industrial use, and external reporting on the framework notes that the 0.3% THC threshold is meant to prevent abuse of medicinal products and reduce recreational misuse.
Here’s the thing: once the state decides THC level matters, hemp and medicinal cannabis stop being marketing words and become legal categories. That is exactly what weak content usually misses.
Industrial hemp under CCRA
THC threshold for industrial hemp
Under the current policy, industrial hemp sits below the 0.3% THC threshold. The official policy says routine testing of industrial cannabis crop shall be conducted by CCRA to verify THC levels and ensure compliance with the permissible threshold of less than 0.3%. The earlier legal framework surfaced in official Senate search results also distinguishes cultivation of cannabis with THC less than 0.3% from cannabis above that threshold.
That means industrial hemp is not “THC-free.” It means it stays below the legal cutoff the regulator uses for low-THC industrial treatment.
Industrial uses and market role
The policy frames industrial cannabis / hemp as part of a value-added market built around cultivation and processing, which aligns with CCRA’s broader push toward industrial development and regulated supply chains. External reporting on Pakistan’s hemp framework also notes that the 0.3% standard is designed to support safe, legal hemp-based products under a controlled system.
For readers who still need the basic definition first, What Is Hemp?.
Medicinal cannabis under CCRA
THC level and controlled access
Medicinal cannabis sits on the stricter side of the line. The policy states that the distribution and sale of medicinal cannabis with THC above 0.3% and its derivatives shall take place through outlets, with prescriptions from registered health professionals. That is a completely different regulatory posture from industrial hemp.
In plain language, medicinal cannabis is not just “stronger hemp.” It is a separately controlled category tied to medical access and tighter oversight.
Prescription-based use and medical oversight
Pakistan’s policy makes medicinal cannabis a prescription-linked category when THC exceeds 0.3%. That means higher-THC cannabis products are not being positioned as open retail wellness items. They are being placed inside a more formal medical channel.
For readers focused on that branch of the topic, Medical Cannabis in Pakistan.
Industrial hemp vs medicinal cannabis: side-by-side comparison
Here is the clearest way to think about it:
Industrial hemp
- THC level: less than 0.3%
- Regulatory role: industrial cannabis / hemp category
- Main focus: cultivation, processing, and industrial value chain
- Testing: routine THC verification by CCRA applies
Medicinal cannabis
- THC level: above 0.3%
- Regulatory role: controlled medicinal category
- Main focus: medical use and regulated derivatives
- Distribution: through outlets with prescriptions from registered health professionals
That comparison matters because a lot of people in Pakistan still talk about hemp, cannabis, CBD, and medicinal products as if the regulator treats them all the same. It does not.
Why this distinction matters for CBD buyers and businesses in Pakistan
This distinction matters because CBD products live close to the boundary where classification can change how a product is regulated. If a product is marketed as hemp-derived, THC content still matters. Pakistan’s policy says THC limits are verified during licensing and that certification and testing clearance by the CCRA Laboratory is mandatory for cannabis, hemp, and cannabinoid-based products.
That means buyers should stop assuming “CBD” automatically tells them everything they need to know. It does not. Businesses should stop assuming “hemp” is enough of an explanation. It is not. In cities like Lahore, Karachi, and Islamabad, where people often buy based on packaging and hype, this is exactly where confusion turns into bad decisions.
For readers focused on the THC threshold itself, THC Limit for Hemp in Pakistan.
Common mistakes people make about hemp and medicinal cannabis
Mistake 1: Thinking hemp and medicinal cannabis are the same
They are not. Under Pakistan’s current framework, the categories are separated by THC level and regulatory treatment.
Mistake 2: Thinking 0.3% means zero THC
Wrong. It means the cutoff for industrial hemp treatment is less than 0.3% THC, not zero.
Mistake 3: Thinking anything called CBD automatically belongs to hemp
Not necessarily. CBD is a cannabinoid, but the regulatory treatment still depends on THC content, source category, and compliance with testing and certification rules.
Mistake 4: Thinking medicinal cannabis means open retail sale
It does not. The policy links medicinal cannabis above 0.3% THC to controlled outlets and prescriptions from registered health professionals.
Final takeaway
Under CCRA, industrial hemp and medicinal cannabis are not the same thing. Industrial hemp falls under the less than 0.3% THC threshold and sits inside the industrial cannabis framework, while medicinal cannabis with more than 0.3% THC is treated as a more tightly controlled medical category tied to prescription-based distribution. That distinction affects cultivation, testing, licensing, compliance, and how buyers and businesses should understand cannabis-derived products in Pakistan.
